Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

The University of Texas at Austin, Austin, Texas

Key details

Phase

Post-approval study

Sponsor

University of Texas at Austin

Collaborators

National Institute on Aging (NIA)

Enrollment target

~156 participants

Started

July 2017

Primary completion

August 2022

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

55 Years and older

Last updated May 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.